Journal article

CHD2 variants are a risk factor for photosensitivity in epilepsy

Elizabeth C Galizia, Candace T Myers, Costin Leu, Carolien GF de Kovel, Tatiana Afrikanova, Maria Lorena Cordero-Maldonado, Teresa G Martins, Maxime Jacmin, Suzanne Drury, V Krishna Chinthapalli, Hiltrud Muhle, Manuela Pendziwiat, Thomas Sander, Ann-Kathrin Ruppert, Rikke S Moller, Holger Thiele, Roland Krause, Julian Schubert, Anna-Elina Lehesjoki, Peter Nuernberg Show all

Brain | OXFORD UNIV PRESS | Published : 2015

Grants

Awarded by Wellcome Trust


Awarded by National Institutes of Health


Awarded by Netherlands National Epilepsy Fund


Awarded by German Research Foundation within the EuroEPINOMICS of the Eurocores program by the European Science Foundation (ESF)


Awarded by EuroEPINOMICS programme (German Research Council, DFG) within the EUROCORES of the European Science Foundation (ESF)


Awarded by European FP6 Marie Curie Excellence Grant on Visual Sensitivity


Funding Acknowledgements

Funding was provided by the Wellcome Trust (SMS, grant 084730), the Henry Smith Charity (SMS), Action Medical Research (SMS), National Institutes of Health (HCM R56NS69605), National Health and Medical Research Council of Australia (SFB, IES), Health Research Council of New Zealand (LGS), The Netherlands National Epilepsy Fund (grant 04-08 to B.P.C.K), German Research Foundation (HE 5415 3-1) within the EuroEPINOMICS framework of the Eurocores program by the European Science Foundation (ESF), intramural funds of the University of Kiel, Germany. H.L., P.N. and T.S. received grants by the EuroEPINOMICS programme (German Research Council, DFG grant numbers: HL: LE1030/11-1; PN: NU50/8-1, TS: SA434/5-1) within the EUROCORES framework of the European Science Foundation (ESF); the collection of the CoGIE cohort was also supported by the EuroEPINOMICS program. Patient collection in Europe was partly made possible thanks to the European FP6 Marie Curie Excellence Grant on Visual Sensitivity MEXCT-CT-2005-024224. CVE is an Industrial Research Fund mandate holder of the KU Leuven. This work was partly undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.